Marplan Tablets

Company
Roche

Approval Status
Approved August 1998

Treatment for
Depression

Areas
Diabetes / Endocrinology , Psychiatry / Psychiatric

Marplan is indicated for the treatment of depression. Because of its potentially serious side effects, it is not recommended as an anti-depressant of first choice in the treatment of newly diagnosed depressed patients.

The effectiveness of Marplan for long-term use, meaning longer than 6 weeks, has not been fully evaluated by trials.

Marplan can cause serious side effects. It is not recommended as initial therapy but should be reserved for patients who have not responded satisfactorily to other anti-depressants.

Some side effects include: headaches, palpitation, neck stiffness, nausea or vomiting, sweating (fevers or clammy skin), photophobia, tachycardia, bradycardia, constricting chest pain, dilated pupils, intracranial bleeding and increased blood pressure.

Marplan_tablets Drug Information

The Marplan_tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top